Michael R. Folkert, MD, PhD, discusses real-world outcomes with spacer in prostate cancer
March 17th 2025"4 years following radiation therapy, there is a 25% lower hazard of bowel disorders and a 46% lower hazard of related procedures [in patients who received a spacer],” says Michael R. Folkert, MD, PhD.